Breast cancer risk assessment by Gail Model (2018)
|
The EBMcalc module
Breast cancer risk assessment by Gail Model (2018) is available in
EBMcalc Complete Edition.
This calculator yields the following results:
- LogRR
- LogRR50
- RRisk
- RRisk50
- R5AVG
- RLAVG
- Risk5
- RiskLife
Equation parameters include:
- Age
- NBiop
- HyperPlasia
- AgeMen
- Age1st
- NRels
References
- Breast Cancer Risk Assessment Tool. National Cancer Institute. https://bcrisktool.cancer.gov/about.html (Accessed on September 20, 2022).
- Banegas MP, John EM, Slattery ML, et al. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women. J Natl Cancer Inst. 2016; 109:djw215. PubMed ID: 28003316
- Matsuno RK, Costantino JP, Ziegler RG, et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst. 2011; 103:951. PubMed ID: 21562243
- Schonfeld SJ, Pee D, Greenlee RT, et al. Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol. 2010; 28:241. PubMed ID: 20368565
- Gail MH, Costantino JP, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst. 2007; 99:1782. PubMed ID: 18042936
- Gail MH, Constantino JP, Bryant J, et al. Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer. J. Natl Cancer Inst. 1999; 91:1829. PubMed ID: 10547390
- Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999; 91:1541. PubMed ID: 10491430
- Benichou J, Gail MH. Estimates of absolute cause-specific risk in cohort studies. Biometrics. 1990; 46:813. PubMed ID: 2242416